Research programme: MOR 102 antibodies - MorphoSysAlternative Names: IgG4 antibody - Morphosys; MOR 102 antibodies; MOR 102 antibodies research programme - MorphoSys; MOR102
Latest Information Update: 16 Mar 2006
At a glance
- Originator MorphoSys
- Class Anti-inflammatories; Antipsoriatics; Monoclonal antibodies
- Mechanism of Action Intercellular adhesion molecule 1 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Psoriasis